This topic contains a solution. Click here to go to the answer

Author Question: Patients with renal disease are at risk for developing megaloblastic anemia because of: a. ... (Read 42 times)

V@ndy87

  • Hero Member
  • *****
  • Posts: 571
Patients with renal disease are at risk for developing megaloblastic anemia because of:
 
  a. Decreased EPO production and utilization
  b. Increased NADPH production
  c. Folate deficiency
  d. Acute blood loss

Question 2

Which of the following tests would help differentiate TEC from DBA?
 
  a. RBC count and RBC indices
  b. Bone marrow cellularity and M:E ratio
  c. Fetal erythrocyte characteristics
  d. Ham test



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Ddddd

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

Correct Answer: C

Answer to Question 2

Correct Answer: C




Ddddd

  • Sr. Member
  • ****
  • Posts: 334

 

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

For a complete list of videos, visit our video library